Replies to post #47328 on Whale Team

[monte379]

CELZ announced today that as a continuation of the Brand Building of its CaverStemTM technology, it has awarded a contract to PatientGain Medical Marketing for the new design of its CaverStemTM website and to provide online strategy with a focus on acquiring and engagement of new patients for physicians offering the CaverStem™ procedure.

In addition to gaining much greater online exposure for the CaverStemTM brand, by utilizing this technology CaverStemTM will interface with each physician's office to facilitate real time responses to patient inquiries and questions. As the CaverStemTM network grows we will be able to scale and maintain our efficiency in communicating with physician's and patient's, scheduling physician consultations and follow up appointments, all conducted under HIPAA compliance," Mr. Warbington further said.

Physician's in several cities are currently being trained on the use of the PatientGain platform and the newly designed Caverstem.com website is expected to launch within the next 10 days.

[NSX]

$CELZ loves to run! GET READY FRIENDS!
$CELZ is a volume leader in the OTCQB
$CELZ is 100% compliant and timely with all SEC filings
$CELZ is an A-Rated SEC OTCQB company
$CELZ ran from $0.002 in march of last year to $0.07 this June!
$CELZ is a commercial stage Bio-technology company with many patents
$CELZ is just in the early phases of commercializing its first patent

$CELZ is domestically and internationally marketing CaverStem TM

$CELZ Company formed the subsidiary CaverStem International LLC for the purpose of commercializing its erectile dysfunction technology to international physicians.

$CELZ has CaverStem™ which received positive reception at international urology conference. Russia was just a start...Switzerland, France, Italy, UAE, and more are about to come on line-get ready.

$CELZ will have Approximately 30% of the 30,000,000 patients in the United States suffering from erectile dysfunction do not respond to drugs like Viagra, Cialis and Levitra, in part due to an underlying degeneration of the muscles, blood vessels, and nerves needed to achieve erections.

$CELZ flagship CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. The erectile dysfunction market is booming! According to a recent report from ResearchAndMarkets.com, the size of the global erectile dysfunction market is expected to reach $4.25 billion by 2023.

All information from DD and recent Microcaps unsolicited article-available upon request!